Harbour Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.7K | Buy |
499
+61
| +14% | +$4K | ﹤0.01% | 2008 |
|
|
2025
Q1 | $30.9K | Buy |
438
+138
| +46% | +$9.74K | ﹤0.01% | 1990 |
|
|
2024
Q4 | $19.7K | Hold |
300
| – | – | ﹤0.01% | 2133 |
|
|
2024
Q3 | $21.2K | Hold |
300
| – | – | ﹤0.01% | 2028 |
|
|
2024
Q2 | $19.9K | Sell |
300
-18
| -6% | -$1.19K | ﹤0.01% | 1957 |
|
|
2024
Q1 | $21.6K | Hold |
318
| – | – | ﹤0.01% | 1919 |
|
|
2023
Q4 | $19.7K | Hold |
318
| – | – | ﹤0.01% | 1885 |
|
|
2023
Q3 | $18.8K | Hold |
318
| – | – | ﹤0.01% | 1768 |
|
|
2023
Q2 | $19K | Hold |
318
| – | – | ﹤0.01% | 1777 |
|
|
2023
Q1 | $18.6K | Buy |
318
+18
| +6% | +$1.05K | ﹤0.01% | 1773 |
|
|
2022
Q4 | $18.6K | Hold |
300
| – | – | ﹤0.01% | 1711 |
|
|
2022
Q3 | $19K | Hold |
300
| – | – | ﹤0.01% | 1673 |
|
|
2022
Q2 | $19K | Buy |
+300
| New | +$19K | ﹤0.01% | 1673 |
|
|
2021
Q4 | $21K | Sell |
309
-54
| -15% | -$3.67K | ﹤0.01% | 1650 |
|
|
2021
Q3 | $22K | Hold |
363
| – | – | ﹤0.01% | 2247 |
|
|
2021
Q2 | $22K | Buy |
363
+300
| +476% | +$18.2K | ﹤0.01% | 2293 |
|
|
2021
Q1 | $4K | Buy |
+63
| New | +$4K | ﹤0.01% | 2982 |
|